Diabetes Diagnostics 2015-2022: Global Strategic B

Dublin, Dec. 16, 2016 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of the "Diabetes Diagnostics - Global Strategic Business Report" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.

This report analyzes the worldwide markets for Diabetes Diagnostics in US$ Thousand by the following Product Segments:

• Continuous Glucose Monitoring (CGM) Systems
• HbA1c Testing Devices
• Blood Glucose Monitoring Devices

The report profiles 58 companies including many key and niche players such as

• Abbott Diabetes Care, Inc. (US)
• Acon Laboratories, Inc. (US)
• AgaMatrix, Inc. (US)
• Alere Inc. (US)
• Animas Corporation (US)
• Apex Biotechnology Corporation (Taiwan)
• ARKRAY, Inc. (Japan)
• Ascensia Diabetes Care Holdings AG (Switzerland)
• A.Menarini Diagnostics Ltd. (UK)
• B. Braun Melsungen AG (Germany)
• Becton, Dickinson and Company (US)
• Bayer Healthcare Diabetes Care (US)
• Beckman Coulter, Inc. (US)
• Bio-Rad Laboratories (US)
• BIONIME Corporation (Taiwan)
• Diazyme Laboratories Inc. (US)
• Dexcom, Inc. (US)
• EKF Diagnostics Holdings Plc (UK)
• HemoCue® AB (Sweden)
• Infopia Co., Ltd. (South Korea)
• LifeScan, Inc. (US)
• Medtronic MiniMed, Inc. (US)
• Nova Biomedical Corporation (US)
• PTS Diagnostics (US)
• Roche Diagnostics (Switzerland)
• Sanofi S.A. (France)
• Sanwa Kagaku Kenkyusho Co, Ltd. (Japan)
• Siemens Healthineers (Germany)
• Taidoc Technology Corporation (Taiwan)
• Tandem Diabetes Care, Inc. (US)
• Terumo Corporation (Japan)
• Tosoh Bioscience, Inc. (US)
• Trinity Biotech plc (Ireland)
• Trividia Health, Inc. (US)
• Ypsomed AG (Switzerland)

Key Topics Covered: 1. Industry Overview 2. Competition 3. Market Trends, Issues & Drivers 4. Diabetes Diagnostics Innovations & Advancements 5. Product Overview 6. Product Launches 7. Recent Industry Activity 8. Focus On Select Global Players 9. Global Market Perspective

Total Companies Profiled: 58 (including Divisions/Subsidiaries 75)

• The United States (35)
• Canada (1)
• Japan (4)
• Europe (23)
• - France (2)
• - Germany (4)
• - The United Kingdom (8)
• - Italy (1)
• - Rest of Europe (8)
• Asia-Pacific (Excluding Japan) (10)
• Middle-East (2)

For more information about this report visit http://www.researchandmarkets.com/research/w859zk/diabetes

CONTACT: Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Related Topics: Diagnostics, Endocrinology